English  |  正體中文  |  简体中文  |  Items with full text/Total items : 94459/94459 (100%)
Visitors : 87656697      Online Users : 242
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: https://ir.lib.ncu.edu.tw/handle/987654321/103195


    Title: Corneal neovascularization and contemporary antiangiogenic therapeutics
    Authors: 陳思妤;Hsu, Chih-Chien;Chang, Hua-Ming;Lin, Tai-Chi;Hung, Kuo-Hsuan;Chien, Ke-Hung;Chen, Szu-Yu;Chen, San-Ni;Chen, Yan-Ting
    Contributors: 理學院光電科學與工程學系
    Keywords: angiogenesis;Angiogenesis Inhibitors - therapeutic use;Animals;antiangiogenesis;corneal neovascularization;Corneal Neovascularization - drug therapy;Disease Models, Animal;Humans;immunosuppressant;Immunosuppressive Agents - therapeutic use;Internal Medicine;Platelet-Derived Growth Factor - physiology;Receptors, Vascular Endothelial Growth Factor - physiology;vascular endothelial growth factor;Vascular Endothelial Growth Factor A - antagonists & inhibitors;Vascular Endothelial Growth Factor A - physiology
    Date: 2015-06-01
    Issue Date: 2026-04-23 11:25:21 (UTC+8)
    Publisher: Elsevier Taiwan LLC;Netherlands: Elsevier Taiwan
    Abstract: 摘要: Corneal neovascularization (NV), the excessive ingrowth of blood vessels from conjunctiva into the cornea, is a common sequela of disease insult that can lead to visual impairment. Clinically, topical steroid, argon laser photocoagulation, and subconjunctival injection of bevacizumab have been used to treat corneal NV. Sometimes, the therapies are ineffective, especially when the vessels are large. Large vessels are difficult to occlude and easily recanalized. Scientists and physicians are now dedicated to overcoming this problem. In this article, we briefly introduce the pathogenesis of corneal NV, and then highlight the existing animal models used in corneal NV research—the alkali-induced model and the suture-induced model. Most of all, we review the potential therapeutic targets (i.e., vascular endothelial growth factor and platelet-derived growth factor) and their corresponding inhibitors, as well as the immunosuppressants that have been discovered in recent years by corneal NV studies.
    其他題名: J Chin Med Assoc
    出版者: Netherlands: Elsevier Taiwan
    出版日期: 2015-06-01
    出處: Journal of the Chinese Medical Association, 2015-06, Vol.78 (6), p.323-330
    資源來源: Elsevier ScienceDirect Journals Complete
    版權: 2015
    版權: Copyright © 2015. Published by Elsevier Taiwan.
    識別號: ISSN: 1726-4901
    識別號: ISSN: 1728-7731
    識別號: EISSN: 1728-7731
    識別號: DOI: 10.1016/j.jcma.2014.10.002
    識別號: PMID: 25687646
    Appears in Collections:[Department of Optics and Photonics] journal & Dissertation

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML32View/Open


    All items in NCUIR are protected by copyright, with all rights reserved.

    社群 sharing

    ::: Copyright National Central University. | 國立中央大學圖書館版權所有 | 收藏本站 | 設為首頁 | 最佳瀏覽畫面: 1024*768 | 建站日期:8-24-2009 :::
    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 隱私權政策聲明